Results 1 to 10 of about 16,191,636 (293)
South African Family Practice, 2015 Schizophrenia is a chronic psychiatric condition. Patients with schizophrenia present clinically with psychotic, negative and cognitive symptoms, which can become evident late in adolescence or in early adulthood.
Nadira Khamker
doaj +3 more sources
Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial [PDF]
Journal of Clinical Psychopharmacology, 2011 Sexual dysfunctions (SDs) occur frequently in schizophrenia patients and have a huge impact on quality of life and compliance. They are often associated with antipsychotic medication.
Fleischhacker, W. Wolfgang +5 more
core +5 more sources
Complement system biomarkers in first episode psychosis [PDF]
Schizophrenia Research, 2019 Several lines of evidence implicate immunological/inflammatory factors in development of schizophrenia. Complement is a key driver of inflammation, and complement dysregulation causes pathology in many diseases.
Di Forti, Marta +8 more
core +3 more sources
Improving outcomes of first‐episode psychosis: an overview
World Psychiatry, 2017 Paolo Fusar-Poli +2 more
exaly +2 more sources
Sex Selection Bias in Schizophrenia Antipsychotic Trials—An Update Systematic Review
Women, 2021 The lack of female participation in antipsychotic trials for schizophrenia poses an important issue regarding its applicability, with direct and real-life repercussions to clinical practice. Here, our aim is to systematically review the sampling sex bias
Lais Fonseca +5 more
doaj +1 more source
Croatian Models and Experience in First-Episode Psychosis Treatment
European Psychiatry, 2022 We have witnessed a significant push towards staging in medicine. That trend has not bypassed psychiatry, with realization that early phases of various disorders present the window for early intervention that is most likely to result in preserving every ...
A. Savic, D. Ostojic, P. Brecic
doaj +1 more source
Acta Psychiatrica Scandinavica, 2022 To provide a comprehensive analysis of cytokine perturbations in antipsychotic‐naïve first‐episode psychosis (FEP) populations and assess the relationship between inflammatory biomarkers and negative symptom severity.
C. Dunleavy +4 more
semanticscholar +1 more source
British Journal of Psychiatry, 2021 Background Treatment-resistant schizophrenia (TRS) is associated with high levels of functional impairment, healthcare usage and societal costs. Cross-sectional studies may overestimate TRS rates because of selection bias.
D. Siskind +8 more
semanticscholar +1 more source
Frontiers in Psychiatry, 2023 BackgroundThere is evidence suggesting racial disparities in diagnosis and treatment in bipolar disorder (BD) and schizophrenia (SZ). The purpose of this study is to compare psychiatric diagnoses and psychotropic use preceding a first episode of mania ...
Manuel Gardea-Resendez +16 more
doaj +1 more source
Klinik Psikiyatri Dergisi, 2023 INTRODUCTION: Substance use is known to trigger psychotic episodes in individuals predisposed to psychosis. Recently, the importance of inflammatory processes in psychotic disorders has been increasingly emphasized. This study aimed to examine the manner
Hidayet Ece Arat Çelik
doaj +1 more source